Related Experiment Videos
Oxybutynin disrupts learning and memory in the rat passive avoidance response
T Sugiyama1, Y C Park, T Kurita
1Department of Urology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-Sayama, Osaka 589, Japan.
Urological Research
|November 7, 1999
Summary
Oxybutynin, used for urinary incontinence, may impair learning and memory. Studies show it decreased retention time in rats, similar to scopolamine, suggesting potential cognitive disruption.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Oxybutynin is a potent antimuscarinic drug used to treat pollakisuria and urinary incontinence.
- Antimuscarinic activity in the central nervous system is linked to amnesia in humans.
Purpose of the Study:
- To investigate the potential disruptive effects of oxybutynin on learning and memory in a rat model.
- To compare the cognitive effects of oxybutynin with scopolamine, a known amnesic agent.
Main Methods:
- Male Wistar rats were administered oxybutynin or scopolamine (reference drug).
- The step-through passive avoidance response (PAR) was used to assess learning and memory.
- Acquisition and retention phases were evaluated by measuring latency time.
Main Results:
- Oxybutynin administration (≥30 mg/kg orally) significantly reduced retention test latency.
- Scopolamine injection (0.5 mg/kg intraperitoneally) also significantly decreased latency time.
- Both drugs demonstrated a similar negative impact on memory retention.
Conclusions:
- Oxybutynin disrupted memory retention in rats, as evidenced by decreased latency in the passive avoidance response.
- The findings suggest that oxybutynin may cause cognitive impairment, specifically affecting learning and memory.
- These results highlight the potential for central nervous system side effects related to oxybutynin's antimuscarinic properties.